Written by Professor Ian Roberts, Professor of Epidemiology at LSHTM and co-lead of the WOMAN-2 Trial. Access to quality health services is a basic human right. This is reflected in …
Written by Professor Ian Roberts, Professor of Epidemiology at LSHTM and co-lead of the WOMAN-2 Trial. Equality, diversity and inclusion are social justice issues at the heart of International Women’s …
After a lot of hard work behind the scenes, we are thrilled to announce that the I’M WOMAN Trial will start recruitment imminently. Trial materials are on route to study …
Written by Professor Ian Roberts, Professor of Epidemiology at LSHTM and co-lead of the WOMAN-2 Trial. On 15 January 2024, a new fact will enter the world. It will take …
As 2023 draws to a close, we reflect on what a year it has been for the WOMAN Trials. Below some of the team give their thoughts on what have …
A paper published today in the Journal of Thrombosis and Haemostasis from authors based at Semmelweis University in Hungary and the London School of Hygiene & Tropical Medicine (LSHTM) shows …
Worldwide, half a billion women are anaemic. This video shows how anaemia affects the blood, causing it to clot less and flow faster, which can increase the risk of excessive …
The World Health Organization (WHO) has released its first roadmap to tackle excessive bleeding after childbirth known as postpartum haemorrhage (PPH). PPH affects millions of women annually and is the …
We’re thrilled to share that the WOMAN-2 Trial has completed recruitment, with 15,000 women randomised across sites in Nigeria, Pakistan, Tanzania, and Zambia. With the unwavering commitment of these dedicated teams, we were able to complete recruitment in September 2023, bringing us a step closer to creating meaningful change for women worldwide.
Professor Rizwana Chaudhri and Professor Ian Roberts speak with The Lancet Global Health about research carried out by the WOMAN Trials collaborators investigating the link between maternal anaemia and postpartum haemorrhage.